antibodies directed against light chain ( p55 ) of interleukin 2 ( il2 ) receptor and able to interfere with il2 binding on the il2-receptor in its high-affinity conformation ( only expressed on activated t cells ) are effective in various animal models and recently in a preventive protocol in human kidney graft recipients .
C0021756
il2
C0086418
human